 Gastrointestinal (GI) symptoms including abdominal pain, bloating diarrhoea relatively common reason consulting physician. may due inflammatory bowel disease (inflammatory bowel disease; Crohn's disease, ulcerative colitis indeterminate colitis), malignancy (colorectal cancer), infectious colitis irritable bowel syndrome (IBS). Differentiation involves use clinical, radiological, endoscopic serological techniques, invasive involve exposure radiation. Serological markers include C-reactive protein, erythrocyte sedimentation rate antibodies (perinuclear antineutrophil cytoplasm antibody anti-Saccharomyces cerevisiae antibody). Faecal markers aid distinguishing inflammatory disorders non-inflammatory conditions non-invasive generally acceptable patient. IBS accounts 50% cases presenting GI clinic diagnosis exclusion (Rome III criteria), test reliably distinguish IBS organic disease could speed diagnosis reduce endoscopy waiting times. Faecal calprotectin, lactoferrin, M2-PK S100A12 reviewed.